NCT03690947View on ClinicalTrials.gov

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

August 31, 2021

Study Completion Date

September 30, 2021

Conditions
Diabetic Macular Edema
Interventions
DRUG

Intravitreal Ranibizumab

All subjections received 3 initial Ranibizumab injections

PROCEDURE

Micropulse Laser

After 3 initial Ranibizumab injections, Micropulse Laser will be done as needed each month if macular edema persists

DRUG

Intravitreal Ranibizumab as needed

After 3 initial Ranibizumab injections, Ranibizumab will be injected as needed till BCVA reaches stabilization

Trial Locations (1)

100730

Beijing Hospital, Beijing

All Listed Sponsors
lead

Beijing Hospital

OTHER_GOV

NCT03690947 - Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME | Biotech Hunter | Biotech Hunter